Income before deduction of interest, taxes and amortization: adialpharma.com (ADIL)

While Adial Pharmaceuticals (ADIL) undergoes complex clinical trials for its personalized agent AD04, the company is successfully implementing ESG standards and biosafety. The EBITDA history on this GURU.Markets chart shows that 0.00 captures a new operating profit level. This is driven by automated biochemical tests, which accelerate drug verification through the robotization of analysis.

ADIL Adial Pharmaceuticals Inc. Operating profit EBITDA (11/23/2025 - 10/29/2026)

Adial Pharmaceuticals, Inc. (ADIL) - metric breakdowns and financial figures

- market price and analyst price targets:

Stock Price Adial Pharmaceuticals Inc.|ADIL - Price Target Chart

- company stock exchange capitalization indicators:

Market Value Adial Pharmaceuticals|ADIL - Total Company Value

- book capitalization information:

Accounting Value per Share Adial Pharmaceuticals|ADIL - Book Capitalization|Market Capitalization to Book Value Ratio adialpharma.com|ADIL - Company Total Assets

- debt level and financial liquidity data:

Debt to Equity Ratio Adial Pharmaceuticals|ADIL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Adial Pharmaceuticals Inc.|ADIL - Company Aggregate Debts|Debts to Book Capitalization Adial Pharmaceuticals|ADIL - Company Long-Term Debt|Company Short-Term Debt Adial Pharmaceuticals|Intermediate Coverage Ratio adialpharma.com

- earnings and multiples data:

ADIL - Company Net Income|Forward Earnings Adial Pharmaceuticals|ADIL - P/E Multiple|Future Price to Earnings Multiple Adial Pharmaceuticals Inc.|ADIL - PEG Multiple|EV/EBITDA Multiple Adial Pharmaceuticals|ADIL - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Adial Pharmaceuticals|ADIL - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months adialpharma.com|ADIL - Earnings growth in current year|Earnings growth forecast for next year Adial Pharmaceuticals

Summary company analytics:ADIL (Adial Pharmaceuticals)

Flagship merchandise of Adial Pharmaceuticals

The high scalability of Adial Pharmaceuticals (ADIL) enables the generation of significant cash flow against fixed production costs for its patented drugs. This metric captures the daily balance of operating profit before depreciation and interest, reflecting the real-time balance of supply and demand, which allows for an assessment of current business efficiency through an EBITDA snapshot.

Competitors of Adial Pharmaceuticals (ADIL)